Founded in 1983 as Pakistan's first private university, Aga Khan University, is a non-profit institution and an agency of the Aga Khan Development Network. Starting in 2000, the university expanded to Kenya, Tanzania, Uganda, United Kingdom and Afghanistan. AKU began life as a health-sciences university.

During the past decade, Aga khan University conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 3 clinical trials were completed, i.e. on average, 3.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 3 clinical trials were completed. i.e. 6.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aga khan University" #1 sponsor was "Aga Khan University" with 81 trials, followed by "NICHD Global Network for Women's and Children's Health" with 10 trials sponsored, "Aga Khan University Hospital, Pakistan" with 5 trials sponsored, "Foundation for Innovative New Diagnostics, Switzerland" with 4 trials sponsored and "The Hospital for Sick Children" with 4 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aga khan University" #1 collaborator was "Aga Khan University" with 22 trials as a collaborator, "Bill and Melinda Gates Foundation" with 14 trials as a collaborator, "World Health Organization" with 7 trials as a collaborator, "RTI International" with 6 trials as a collaborator and "Jawaharlal Nehru Medical College" with 5 trials as a collaborator. Other collaborators include 159 different institutions and companies that were collaborators in the rest 121 trials.

According to Clinical.Site data, the most researched conditions in "Aga khan University" are "Hypertension" (7 trials), "Stunting" (5 trials), "Anemia" (4 trials), "Malnutrition" (4 trials) and "Pregnancy" (4 trials). Many other conditions were trialed in "Aga khan University" in a lesser frequency.

Most popular intervention types in "Aga khan University" are "Drug" (33 trials), "Other" (28 trials), "Behavioral" (27 trials), "Device" (10 trials) and "Dietary Supplement" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Azithromycin" (2 trials), "Community Mobilization" (2 trials), "Lactulose" (2 trials) and "2% lidocaine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Aga khan University" are 104 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 28 active trials in "Aga khan University". 5 are not yet recruiting, 16 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 73 completed trials in Aga khan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aga khan University, 2 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 56 trials that are defined as “Not Applicable".

Aga khan University has several departments that took part in Clinical trials: "Aga Khan Hospital for Women and Children (AKHWC)" - 2 trials